CellReady is specifically designed to cut two years, and millions of dollars, off the path that cell and gene therapy (CGT) companies take to acquire the meaningful clinical inflection points that investors demand.
CGT companies are funded by investors that expect to see their money generate meaningful clinical data before they make additional investments. But that rarely happens.
Instead of spending the money on clinical data, CGT companies burn through 5%-10% of their investor's money each month while they struggle to create the essential building blocks of their CGT company, such as a quality management system, scalable manufacturing process, and a CMC section that is sure to clear FDA scrutiny.
The CGT industry now faces a crisis. Investors no longer tolerate this time-consuming approach that leaves them empty handed.
CellReady solves the problem by allowing CGT companies to hit the ground running with all of the essential building blocks they need to quickly gather meaningful clinical data.
And CellReady is not driven solely by profit. CellReady will provide CGT companies with an optimized, scalable, and standardized G-Rex centric cell manufacturing process at virtually no charge, a nimble quality management system for free, ready-made sections of the CMC that will clear FDA review, and a vast array of expertise in all technical and business aspects of running a successful CGT company.
Company Details
- Employees
- 27
- Founded
- -
- Address
- 4551 Kennedy Commerce Drive, Houston,tx 77032,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.wilsonwolf.com
- Keywords
- Biotechnology Research.
- HQ
- Houston, TX
Cellready™ Questions
Cellready™'s website is http://www.wilsonwolf.com
Cellready™'s LinkedIn profile is https://www.linkedin.com/company/cellready
Cellready™ has
27 employees.
View email and phone details for 27
employees at Cellready™.
Cellready™'s industry is
Biotechnology Research
Cellready™'s top competitors are
Kiromic Biopharma, Inc.,
Marker Therapeutics, Inc.,
Ctmc,
Wilson Wolf Manufacturing, Llc,
Vgxi,
Cellipont Bioservices,
Scaleready,
Immatics,
Packgene Biotech, Inc.,
Lonza.
Cellready™'s categories are Biotechnology Research
Cellready™'s founding year is 2023
